Gebrehiwot Abraham

Summary

Affiliation: Centre for Addiction and Mental Health
Country: Canada

Publications

  1. ncbi T3 augmentation of SSRI resistant depression
    Gebrehiwot Abraham
    Department of Psychiatry, University of Toronto, ON, Canada
    J Affect Disord 91:211-5. 2006
  2. ncbi Clinical outcome and memory function with maintenance electroconvulsive therapy: a retrospective study
    Gebrehiwot Abraham
    Centre for Addiction and Mental Health, West, Toronto, Ontario, Canada
    J ECT 22:43-5. 2006
  3. ncbi Add-on quetiapine for bipolar depression: a 12-month open-label trial
    Roumen Milev
    Department of Psychiatry, Queen s University, Kingston, Ontario
    Can J Psychiatry 51:523-30. 2006
  4. ncbi Quetiapine: novel uses in the treatment of depressive and anxiety disorders
    Arun V Ravindran
    University of Toronto, Ontario, Toronto, Canada
    Expert Opin Investig Drugs 19:1187-204. 2010

Detail Information

Publications4

  1. ncbi T3 augmentation of SSRI resistant depression
    Gebrehiwot Abraham
    Department of Psychiatry, University of Toronto, ON, Canada
    J Affect Disord 91:211-5. 2006
    ..To investigate whether the addition of triiodothyronine (T3) helps relieve depressive symptoms in non-hypothyroid major depressive disorder patients who failed to respond to an adequate course of standard SSRI antidepressant treatments...
  2. ncbi Clinical outcome and memory function with maintenance electroconvulsive therapy: a retrospective study
    Gebrehiwot Abraham
    Centre for Addiction and Mental Health, West, Toronto, Ontario, Canada
    J ECT 22:43-5. 2006
    ....
  3. ncbi Add-on quetiapine for bipolar depression: a 12-month open-label trial
    Roumen Milev
    Department of Psychiatry, Queen s University, Kingston, Ontario
    Can J Psychiatry 51:523-30. 2006
    ..Our study also sought to assess the safety and tolerability of quetiapine in patients with BD...
  4. ncbi Quetiapine: novel uses in the treatment of depressive and anxiety disorders
    Arun V Ravindran
    University of Toronto, Ontario, Toronto, Canada
    Expert Opin Investig Drugs 19:1187-204. 2010
    ..However, it is often used (off-label) to treat other depressive disorders and anxiety disorders in children and adults...